Market closedNon-fractional
The Cooper Companies/COO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About The Cooper Companies
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Ticker
COO
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
San Ramon, United States
Employees
15,000
Website
www.coopercos.com
COO Metrics
BasicAdvanced
$18B
Market cap
54.61
P/E ratio
$1.70
EPS
0.97
Beta
$0.01
Dividend rate
0.01%
Dividend yield
Price and volume
Market cap
$18B
Beta
0.97
Dividend rate
$0.01
Financial strength
Current ratio
1.952
Quick ratio
0.841
Long term debt to equity
37.791
Total debt to equity
38.326
Dividend payout ratio (TTM)
0.44%
Interest coverage (TTM)
5.08%
Management effectiveness
Return on assets (TTM)
3.01%
Return on equity (TTM)
4.48%
Valuation
Price to earnings (TTM)
54.608
Price to revenue (TTM)
4.929
Price to book
2.37
Price to tangible book (TTM)
8.22
Price to free cash flow (TTM)
150.387
Dividend yield (TTM)
0.01%
Growth
Revenue change (TTM)
8.87%
Earnings per share change (TTM)
16.91%
3-year revenue growth (CAGR)
11.95%
3-year earnings per share growth (CAGR)
-47.72%
3-year dividend per share growth (CAGR)
-20.63%
What the Analysts think about COO
Analyst Ratings
Majority rating from 20 analysts.
COO Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$943M
1.18%
Net income
$89M
9.48%
Profit margin
9.43%
8.27%
COO Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$0.84
$0.87
$0.85
$0.85
-
Expected
$0.83
$0.87
$0.78
$0.83
$0.91
Surprise
0.32%
-0.16%
8.59%
2.63%
-
COO News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for The Cooper Companies stock?
The Cooper Companies (COO) has a market cap of $18B as of July 26, 2024.
What is the P/E ratio for The Cooper Companies stock?
The price to earnings (P/E) ratio for The Cooper Companies (COO) stock is 54.61 as of July 26, 2024.
Does The Cooper Companies stock pay dividends?
Yes, the The Cooper Companies (COO) stock pays dividends to shareholders. As of July 26, 2024, the dividend rate is $0.0075 and the yield is 0.01%. The Cooper Companies has a payout ratio of 0.44% on a trailing twelve-month basis.
When is the next The Cooper Companies dividend payment date?
The next The Cooper Companies (COO) dividend payment date is unconfirmed.
What is the beta indicator for The Cooper Companies?
The Cooper Companies (COO) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell The Cooper Companies stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.